Fuji Pharma, a Japan-based pharmaceutical company listed on the Tokyo Stock Exchange (TSE), along with its group company OLIC (Thailand) Limited, is mainly engaged in the manufacture and sale of prescription-based pharmaceutical products.
Since our establishment in 1965, Fuji has promoted the corporate philosophy that “We help people lead healthy lives by offering excellent pharmaceuticals.” and “Our corporate growth is proportional to our personal growth.” Fuji focuses on women’s healthcare with a wide variety of drugs for women’s specific diseases, dysmenorrhea, endometriosis, menopausal disorders, infertility, and contraception. Furthermore, in our mid-term management plan 2025-2029, Fuji has also identified biosimilar business and global CMO business as key focus areas alongside women’s healthcare. Fuji is expanding product lineup to provide new treatment options to patients and medical professionals. Fuji will continue to create new value in women’s healthcare and contribute to society where everyone can enjoy well-being.
